Rheumatology Fellows' Meeting: National Psoriasis Foundation

Rheumatology Fellows' Meeting

The inaugural Rheumatology Fellows' Meeting is modeled after NPF’s highly successful and longest-running educational program, the Residents’ Meeting, and is a one-and-a-half-day program that focuses on educating rheumatology fellows about recent advances in treatments and the management of psoriasis and psoriatic arthritis. The 2023 Rheumatology Fellows Meeting will be held in Washington, D.C., on Saturday, October 7, and Sunday, October 8, and will include joint sessions with dermatology residents as well as breakout sessions specifically for rheumatology fellows.

What you can expect:

A one-and-a-half-day program providing a comprehensive psoriatic disease curriculum for rheumatology fellows
Evidence-based sessions presented by expert leaders in the field of psoriasis and psoriatic arthritis
Detailed overview of the clinical, medical, psychosocial, and economic impact of psoriatic disease and its management
Review of recent advances in the treatment of psoriasis, psoriatic arthritis, and its associated comorbid disease states
Explore the diagnosis and management of psoriatic disease in skin of color and special patient populations
Examine strategies to alleviate the cost and barriers associated with psoriatic disease treatment options
Opportunities for fellows to network with each other, industry partners, and leading academic dermatologists and rheumatologists from various practice settings across the U.S.

The Chairs for this first-ever NPF Rheumatology Fellows Meeting are Alice B Gottlieb, M.D., Ph.D., Medical Director, Beth Israel Dermatology, Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai, and Joseph F. Merola, M.D., MMSc, FAAD, Vice Chair, Clinical Trials and Innovation, Department of Dermatology, Director, Clinical Unit for Research Innovation and Trials (CUReIT), Director, Center for Skin and Related Musculoskeletal Diseases, Associate Program Director, Harvard Combined Internal Medicine-Dermatology Residency Training Program, and Associate Professor, Harvard Medical School.

This 2023 Dermatology Residents and Rheumatology Fellows Meeting on Psoriatic Disease is provided by the National Psoriasis Foundation. It is supported by educational grants from Janssen Biotech, Inc. and Pfizer Inc. and sponsored by NPF's corporate members. It is also supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Applications Are Now Closed

Questions about your application? Email us at medicalaffairs@psoriasis.org.

Learn about Travel and Lodging Information.

View all upcoming CME events

Alice Gottlieb, M.D., Ph.D.

Clinical Professor, Mount Sinai

Dr. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. She is a Professor of Dermatology at New York Medical College and is triple-board certified in dermatology, rheumatology, and internal medicine – making her one of only a handful of doctors in the U.S. to be certified in all three specialties.

Over the course of her illustrious career, Dr. Gottlieb has held many leadership positions, published over 400 groundbreaking peer-reviewed articles, and presented her original research at more than 300 dermatology and rheumatology conferences in the U.S. and internationally. She is the recipient of many awards for excellence in teaching and research.

Dr. Gottlieb’s work has contributed to drug development in psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and transplantation. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, to better understand the diagnosis and management of psoriatic disease.

Joseph F Merola, M.D., MMSc, FAAD, FACR

Associate Professor in the Department of Dermatology and the Department of Medicine’s Division of Rheumatology at Harvard Medical School

Dr. Merola holds board certifications in dermatology, internal medicine, and rheumatology. At Harvard, Dr. Merola serves as Vice Chair and Director of the Clinical Unit for Research Innovation and Trials (CUReIT), Director of the Center for Skin and Related Musculoskeletal Diseases, and Associate Director for the Harvard Combined Internal Medicine-Dermatology Residency Training Program at Brigham and Women’s Hospital (BWH) in Boston, MA.

He earned his medical degree at New York University (NYU) and attained his Master of Medical Sciences degree at Harvard Medical School. Dr. Merola completed his internal medicine internship at the Hospital of the University of Pennsylvania, a dermatology residency at NYU, and an internal medicine residency and rheumatology fellowship at BWH.

He is on the board of the National Psoriasis Foundation, the International Dermatology Outcome Measures Group, and the Lupus Foundation of America. Additionally, Dr. Merola is the Founding President and on the board of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) and is a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Steering Committee.